Literature DB >> 4349053

Biosynthesis of lymph and plasma lipoprotein apoproteins by isolated perfused rat liver and intestine.

H G Windmueller, P N Herbert, R I Levy.   

Abstract

The ability of rat intestine and liver to synthesize the various apoproteins of plasma lipoproteins was investigated. After the individual isolated organs were perfused with blood containing [(3)H]lysine, chylomicrons plus very low density lipoproteins (VLDL), low density lipoproteins (LDL), and high density lipoproteins (HDL) were isolated from the perfusates and the intestinal lymph. After lipoprotein delipidation, apoproteins were separated by polyacrylamide gel electrophoresis and the (3)H content was determined. Livers incorporated [(3)H]lysine into all apoprotein bands of VLDL and HDL. The (3)H content was greater in large proteins that remained in the stacking gel (group I, predominantly beta-apoprotein) than in proteins with apparent molecular weights near 50,000 (group II) or in the smaller peptides (molecular weights near 10,000, group III). In the intestine, (3)H was incorporated into group I and, in larger amounts, into group II apoproteins of lymph VLDL. No labeled VLDL appeared in the perfusate. (3)H was also incorporated into group II apoproteins of lymph and perfusate HDL. Significantly, no [(3)H]lysine was found in the group III peptides of any lymph or intestinal perfusate lipoproteins. Since these peptides were always present in VLDL from mesenteric lymph collected in vivo, the results suggest that nascent VLDL of gut origin acquires group III peptides from other lipoproteins that penetrate lymph from plasma.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4349053

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  30 in total

1.  The composition and metabolism of high density lipoprotein subfractions.

Authors:  E J Schaefer; D M Foster; L L Jenkins; F T Lindgren; M Berman; R I Levy; H B Brewer
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

2.  The role of high density lipoprotein apolipoprotein CII in triglyceride metabolism.

Authors:  M L Kashyap; L S Srivastava; B A Hynd; G Perisutti; D W Brady; P Gartside; C J Glueck
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

3.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

4.  Properties of the plasma very low and low density lipoproteins in Tangier disease.

Authors:  R J Heinen; P N Herbert; D S Fredrickson
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

5.  Catabolism of very low density lipoprotein B apoprotein in man.

Authors:  M F Reardon; N H Fidge; P J Nestel
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

6.  [Tangier-disease (author's transl)].

Authors:  G Assmann
Journal:  Klin Wochenschr       Date:  1979-01-15

7.  Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects.

Authors:  P R Turner; N E Miller; C Cortese; W Hazzard; J Coltart; B Lewis
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

8.  Effects of C apoproteins on the activity of endothelium-bound lipoprotein lipase.

Authors:  T W Lukens; J Borensztajn
Journal:  Biochem J       Date:  1978-12-01       Impact factor: 3.857

9.  Experimental nephrotic syndrome in the rat induced by puromycin aminonucleoside: hepatic synthesis of lipoproteins and apolipoproteins.

Authors:  E Gherardi; M Messori; R Rozzi; S Calandra
Journal:  Lipids       Date:  1980-10       Impact factor: 1.880

10.  The intestine as a source of apolipoprotein A1.

Authors:  R M Glickman; P H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.